{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T14:37:49Z","timestamp":1770043069083,"version":"3.49.0"},"reference-count":24,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T00:00:00Z","timestamp":1536278400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0203392","type":"journal-article","created":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T13:42:10Z","timestamp":1536327730000},"page":"e0203392","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":19,"title":["Prognostic utility of serum free light chain ratios and heavy-light chain ratios in multiple myeloma in three PETHEMA\/GEM phase III clinical trials"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1727-8546","authenticated-orcid":true,"given":"Lucia","family":"Lopez-Anglada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilia","family":"Cueto-Felgueroso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Rosi\u00f1ol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert","family":"Oriol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Isabel","family":"Teruel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Lopez de la Guia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrique","family":"Bengoechea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Palomera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felipe","family":"de Arriba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Mariano","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miquel","family":"Granell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco Javier","family":"Pe\u00f1alver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramon","family":"Garcia-Sanz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Besalduch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yolanda","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael Benigno","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel Teodoro","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norma C.","family":"Gutierrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paloma","family":"Puerta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Valeri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Paiva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan","family":"Blade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria-Victoria","family":"Mateos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesus","family":"San Miguel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Jose","family":"Lahuerta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joaquin","family":"Martinez-Lopez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"on behalf of the GEM (Grupo Espa\u00f1ol de MM)\/PETHEMA (Programa para el Estudio de la Terap\u00e9utica en Hemopat\u00edas Malignas) Cooperative Study Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2018,9,7]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1365-2141.2004.05045.x","article-title":"Serum free light chains for monitoring multiple myeloma","volume":"126","author":"GP Mead","year":"2004","journal-title":"Br J Haematol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1515\/cclm-2015-0938","article-title":"Free light chain testing for the diagnosis, monitoring and prognostication of AL amyloidosis","volume":"54","author":"P Mollee","year":"2016","journal-title":"Clin Chem Lab Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1182\/blood-2005-03-1038","article-title":"Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance","volume":"106","author":"SV Rajkumar","year":"2005","journal-title":"Blood"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1177\/0004563213518758","article-title":"Serum-free light-chain assay: clinical utility and limitations","volume":"51","author":"MV Bhole","year":"2014","journal-title":"Ann Clin Biochem"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1373\/clinchem.2014.231985","article-title":"Monitoring IgA multiple myeloma: immunoglobulin heavy\/light chain assays","volume":"61","author":"JA Katzmann","year":"2015","journal-title":"Clin Chem"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/leu.2012.189","article-title":"Suppression of uninvolved immunoglobulins defined by heavy\/light chain pair suppression is a risk factor for progression of MGUS","volume":"27","author":"JA Katzmann","year":"2013","journal-title":"Leukemia"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1365-2141.2007.06561.x","article-title":"Prognostic value of serum free light chain ratio at diagnosis in multiple myeloma","volume":"137","author":"MC Kyrtsonis","year":"2007","journal-title":"Br J Haematol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1182\/blood-2007-01-067728","article-title":"High serum-free light chain levels and their rapid reduction in response to therapy define an aggressive multiple myeloma subtype with poor prognosis","volume":"110","author":"F van Rhee","year":"2007","journal-title":"Blood"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1038\/leu.2008.171","article-title":"Prognostic value of the serum free light chain ratio in newly diagnosed myeloma: proposed incorporation into the international staging system","volume":"22","author":"CL Snozek","year":"2008","journal-title":"Leukemia"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/cei.12011","article-title":"Defining the impact of individual sample variability on routine immunoassay of serum free light chains (sFLC) in multiple myeloma","volume":"171","author":"SH Murng","year":"2013","journal-title":"Clin Exp Immunol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/hon.2026","article-title":"Re-evaluation of prognostic markers including staging, serum free light chains or their ratio and serum lactate dehydrogenase in multiple myeloma patients receiving novel agents","volume":"31","author":"D Maltezas","year":"2013","journal-title":"Hematol Oncol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1038\/sj.leu.2404284","article-title":"International uniform response criteria for multiple myeloma","volume":"20","author":"BG Durie","year":"2006","journal-title":"Leukemia"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1038\/leu.2015.118","article-title":"Utility of serum free light chain measurements in multiple myeloma patients not achieving complete response to therapy","volume":"29","author":"M Alhaj Moustafa","year":"2015","journal-title":"Leukemia"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/ejh.12556","article-title":"Multicentered patient-based evidence of the role of free light chain ratio normalization in multiple myeloma disease relapse","volume":"96","author":"J Radocha","year":"2016","journal-title":"Eur J Haematol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1182\/blood-2015-04-638742","article-title":"Critical analysis of the stringent complete response in multiple myeloma: contribution of sFLC and bone marrow clonality","volume":"126","author":"J Martinez-Lopez","year":"2015","journal-title":"Blood"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1182\/blood-2016-07-726778","article-title":"Serum free light chains, not urine specimens, should be used to evaluate response in light-chain multiple myeloma","volume":"128","author":"T Dejoie","year":"2016","journal-title":"Blood"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"3952","DOI":"10.1002\/cncr.28946","article-title":"IgA kappa\/IgA lambda heavy\/light chain assessment in the management of patients with IgA myeloma","volume":"120","author":"EM Boyle","year":"2014","journal-title":"Cancer"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1373\/clinchem.2009.123828","article-title":"Assessment of monoclonal gammopathies by nephelometric measurement of individual immunoglobulin kappa\/lambda ratios","volume":"55","author":"AR Bradwell","year":"2009","journal-title":"Clin Chem"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/leu.2012.197","article-title":"Immunoglobulin heavy\/light chain ratios improve paraprotein detection and monitoring, identify residual disease and correlate with survival in multiple myeloma patients","volume":"27","author":"H Ludwig","year":"2013","journal-title":"Leukemia"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1182\/blood-2012-02-408922","article-title":"Superiority of bortezomib, thalidomide, and dexamethasone (VTD) as induction pretransplantation therapy in multiple myeloma: a randomized phase 3 PETHEMA\/GEM study","volume":"120","author":"L Rosinol","year":"2012","journal-title":"Blood"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1182\/blood-2014-05-573733","article-title":"GEM2005 trial update comparing VMP\/VTP as induction in elderly multiple myeloma patients: do we still need alkylators?","volume":"124","author":"MV Mateos","year":"2014","journal-title":"Blood"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1182\/blood-2015-08-666537","article-title":"Sequential vs alternating administration of VMP and Rd in elderly patients with newly diagnosed MM","volume":"127","author":"MV Mateos","year":"2016","journal-title":"Blood"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U","article-title":"A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival","volume":"36","author":"BG Durie","year":"1975","journal-title":"Cancer"},{"key":"ref24","article-title":"Heavy+light chain monitoring correlates with clinical outcome in multiple myeloma patients","author":"M Michallet","year":"2017","journal-title":"Leukemia.<"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0203392","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T19:02:11Z","timestamp":1588964531000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0203392"}},"subtitle":[],"editor":[{"given":"Jianjun","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,9,7]]},"references-count":24,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2018,9,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0203392","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,7]]}}}